Richter P, Badescu M, Rezus C, Ouatu A, Dima N, Popescu D
Int J Mol Sci. 2024; 25(20).
PMID: 39457063
PMC: 11509045.
DOI: 10.3390/ijms252011281.
Sorice M, Profumo E, Capozzi A, Recalchi S, Riitano G, Di Veroli B
Biomolecules. 2023; 13(8).
PMID: 37627286
PMC: 10452087.
DOI: 10.3390/biom13081221.
Devreese K, Zuily S, Meroni P
J Transl Autoimmun. 2021; 4:100134.
PMID: 34816113
PMC: 8592860.
DOI: 10.1016/j.jtauto.2021.100134.
Elbagir S, Grosso G, Mohammed N, Elshafie A, Elagib E, Zickert A
Lupus. 2021; 30(8):1289-1299.
PMID: 33957795
PMC: 8209767.
DOI: 10.1177/09612033211014570.
Lackner K, Muller-Calleja N
Antibodies (Basel). 2019; 5(2).
PMID: 31557996
PMC: 6698834.
DOI: 10.3390/antib5020015.
Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-β2-GPI antibodies.
Capozzi A, Manganelli V, Riitano G, Recalchi S, Truglia S, Alessandri C
Clin Exp Immunol. 2018; 196(1):59-66.
PMID: 30549270
PMC: 6422660.
DOI: 10.1111/cei.13248.
Reimagining the antiphospholipid syndrome, an enigmatic thrombophilic disorder, through the looking glass of microscopic imaging.
Rand J, Taatjes D
Histochem Cell Biol. 2018; 150(5):529-543.
PMID: 30121745
DOI: 10.1007/s00418-018-1709-2.
A Monocentric Cohort of Obstetric Seronegative Anti-Phospholipid Syndrome.
Truglia S, Capozzi A, Mancuso S, Recalchi S, Spinelli F, Perricone C
Front Immunol. 2018; 9:1678.
PMID: 30079071
PMC: 6062588.
DOI: 10.3389/fimmu.2018.01678.
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.
Sciascia S, Amigo M, Roccatello D, Khamashta M
Nat Rev Rheumatol. 2017; 13(9):548-560.
PMID: 28769114
DOI: 10.1038/nrrheum.2017.124.
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
Nuri E, Taraborelli M, Andreoli L, Tonello M, Gerosa M, Calligaro A
Immunol Res. 2016; 65(1):17-24.
PMID: 27406736
DOI: 10.1007/s12026-016-8812-z.
Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies".
Manganelli V, Capozzi A, Recalchi S, Signore M, Mattei V, Garofalo T
J Immunol Res. 2015; 2015:847985.
PMID: 26491702
PMC: 4603604.
DOI: 10.1155/2015/847985.
"New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome.
Misasi R, Capozzi A, Longo A, Recalchi S, Lococo E, Alessandri C
J Immunol Res. 2015; 2015:858542.
PMID: 25874238
PMC: 4383493.
DOI: 10.1155/2015/858542.
The mosaic of "seronegative" antiphospholipid syndrome.
Conti F, Capozzi A, Truglia S, Lococo E, Longo A, Misasi R
J Immunol Res. 2014; 2014:389601.
PMID: 24741593
PMC: 3987929.
DOI: 10.1155/2014/389601.
The spectrum between antiphospholipid syndrome and systemic lupus erythematosus.
Agmon-Levin N, Shoenfeld Y
Clin Rheumatol. 2014; 33(3):293-5.
PMID: 24435353
DOI: 10.1007/s10067-014-2486-5.
Detection of anticardiolipin antibody IgG by time-resolved fluoroimmunoassay.
Ye Y, Hu Z, Liu J, Chen G, Zhou Y, Yu L
Clin Rheumatol. 2012; 31(9):1339-45.
PMID: 22684164
DOI: 10.1007/s10067-012-2020-6.
Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopenia.
Yang Y, Yun G, Song I, Baek S, Lee K, Ryu H
Korean J Intern Med. 2011; 26(4):449-54.
PMID: 22205846
PMC: 3245394.
DOI: 10.3904/kjim.2011.26.4.449.
Multiple steno-obstructive vascular lesions and femoral superficial artery dissection in a young Caucasian male with antiphospholipid syndrome.
Cianci R, Gigante A, Barbano B, Zaccaria A, Polidori L, Borghesi F
BMJ Case Rep. 2011; 2009.
PMID: 21686361
PMC: 3029825.
DOI: 10.1136/bcr.12.2008.1342.
Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.
Boin F, Franchini S, Colantuoni E, Rosen A, Wigley F, Casciola-Rosen L
Arthritis Rheum. 2009; 60(8):2480-9.
PMID: 19644882
PMC: 2746063.
DOI: 10.1002/art.24684.
Infections and the antiphospholipid syndrome.
Garcia-Carrasco M, Galarza-Maldonado C, Mendoza-Pinto C, Escarcega R, Cervera R
Clin Rev Allergy Immunol. 2008; 36(2-3):104-8.
PMID: 19089659
DOI: 10.1007/s12016-008-8103-0.
Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.
Atanassova P
Yonsei Med J. 2007; 48(6):901-26.
PMID: 18159581
PMC: 2628175.
DOI: 10.3349/ymj.2007.48.6.901.
